Amrize (NYSE:AMRZ) Director Buys $94,680.00 in Stock

Amrize Ltd (NYSE:AMRZ) Director Nicholas Gangestad bought 2,000 shares of the firm’s stock in a transaction on Wednesday, November 19th. The shares were bought at an average cost of $47.34 per share, with a total value of $94,680.00. Following the purchase, the director directly owned 4,958 shares in the company, valued at approximately $234,711.72. This trade represents a 67.61% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Amrize Trading Down 0.5%

AMRZ stock traded down $0.26 during mid-day trading on Thursday, hitting $47.24. The stock had a trading volume of 3,123,061 shares, compared to its average volume of 3,637,082. The business’s fifty day moving average price is $49.75. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $56.29. The stock has a market cap of $26.13 billion and a PE ratio of 25.73. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42.

Amrize (NYSE:AMRZ) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company’s revenue for the quarter was up 6.6% on a year-over-year basis.

Institutional Trading of Amrize

A number of institutional investors have recently bought and sold shares of AMRZ. Allspring Global Investments Holdings LLC bought a new stake in Amrize in the second quarter valued at about $62,646,000. Credit Industriel ET Commercial acquired a new position in Amrize in the 2nd quarter worth $109,000. TD Asset Management Inc bought a new position in shares of Amrize during the second quarter worth about $8,190,000. Generali Asset Management SPA SGR acquired a new stake in shares of Amrize in the second quarter valued at approximately $4,923,000. Finally, Allianz Asset Management GmbH bought a new stake in Amrize during the 2nd quarter worth about $158,530,000.

Wall Street Analysts Forecast Growth

AMRZ has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised their price objective on Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research note on Tuesday, August 26th. Stephens assumed coverage on Amrize in a research note on Friday, November 14th. They set an “overweight” rating and a $60.00 price target on the stock. Wells Fargo & Company boosted their price target on shares of Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Zacks Research raised Amrize from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Finally, Kepler Capital Markets upgraded shares of Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $58.88.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.